<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00946127</url>
  </required_header>
  <id_info>
    <org_study_id>NA_00014030</org_study_id>
    <nct_id>NCT00946127</nct_id>
  </id_info>
  <brief_title>ETV Versus Shunt Surgery in Normal Pressure Hydrocephalus</brief_title>
  <official_title>Endoscopic Third Ventriculostomy (ETV) Versus Ventriculoperitoneal Shunting (VPS) for the Surgical Management of Normal Pressure Hydrocephalus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Johns Hopkins University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to test and compare the efficacy of Endoscopic Third
      Ventriculostomy with shunting of Cerebrospinal fluid (CSF)for treatment for patients of
      Normal pressure Hydrocephalus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Normal pressure Hydrocephalus is a reversible disorder of cognition and gait
      disorder.Currently the shunting of CSF is the recommended treatment of these patients. Even
      though shunts are known to be beneficial treatment of Hydrocephalus they often need treatment
      or revision for infection or malfunction. Endoscopic Third Ventriculostomy is a treatment
      without complications of shunt and is known to benefit obstructive forms of hydrocephalus.Few
      studies have also shown that it may be efficacious treatment Normal pressure Hydrocephalus.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Unable to recruit patients and lack of efficacy in ETV arm
  </why_stopped>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">October 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy: Cognitive outcomes using RAVLT scale. Gait Outcomes evaluated based on Tinneti Gait and Balance Test. Functional Independence evaluated using Barthel index.</measure>
    <time_frame>1, 3, 6, 12 months after surgery</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>0 through 12 months from Surgery</time_frame>
    <description>Incidence of operative complications related to insertion of a shunt or performing ETV Intra-operative hemorrhage Post Operative amnesia Post Operative hemorrhage Infections Others Incidence of complications related to either of the two procedure over long term follow-up Infection Shunt malfunction ETV closure Others</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy: Cognitive changes using Trails A&amp; B. Gait changes based upon Timed Up and Go task and Gait Rite analysis.</measure>
    <time_frame>1 months, 3 months, 6 months and 1 year</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">13</enrollment>
  <condition>Hydrocephalus</condition>
  <arm_group>
    <arm_group_label>Shunt Arm</arm_group_label>
    <description>Ventriculoperitoneal Shunt</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ETV arm</arm_group_label>
    <description>Endoscopic Third Ventriculostomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ventriculoperitoneal Shunt Placement</intervention_name>
    <description>In the subjects who choose this arm, at the start of study- CSF (Cerebrospinal fluid ) will be shunted to peritoneum by placing a ventriculoperitoneal shunt catheter with or without shunt valves or anti-siphon device.</description>
    <arm_group_label>Shunt Arm</arm_group_label>
    <other_name>Hydrocephalus Shunt Component - Catheter-manufacturer- Medtronic Neurosurgery Inc</other_name>
    <other_name>Codman and Hakim Shunt System--manufacturer-Codman &amp; Shurtleff, Inc.</other_name>
    <other_name>Medtronic PS Polyurethane Shunt--manufacturer-Medtronic Neurosurgery Inc</other_name>
    <other_name>Miethke proGAV shunt system-manufacturer- Aesculap Inc</other_name>
    <other_name>Medtronic PS Strata Medical Valve--manufacturer-Medtronic Neurosurgery Inc</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Endoscopic Third Ventriculostomy(ETV)</intervention_name>
    <description>Patients who choose to undergo ETV arm would undergo a ventriculostomy at the start of study.</description>
    <arm_group_label>ETV arm</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients suspected of Normal pressure hydrocephalus i.e. - with gait disturbances and/ or
        cognitive disturbances and/or urinary incontinence with dilation of ventricles on CT or
        MRI.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with NPH

          -  Meet at least 2 of 3 Hakim and Adams diagnostic criterion for NPH (dementia, gait
             instability and urinary incontinence)

          -  Ventriculomegaly defined by CT or MRI, Evans' index &gt; 0.3

          -  Clinical improvement after 3 day trial of CSF drainage.

          -  MMSE&gt;24

          -  Informed consent from patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniele Rigamonti, MD, FACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Johns Hopkins Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Gangemi M, Maiuri F, Buonamassa S, Colella G, de Divitiis E. Endoscopic third ventriculostomy in idiopathic normal pressure hydrocephalus. Neurosurgery. 2004 Jul;55(1):129-34; discussion 134. Review.</citation>
    <PMID>15214981</PMID>
  </reference>
  <reference>
    <citation>Gangemi M, Maiuri F, Naddeo M, Godano U, Mascari C, Broggi G, Ferroli P. Endoscopic third ventriculostomy in idiopathic normal pressure hydrocephalus: an Italian multicenter study. Neurosurgery. 2008 Jul;63(1):62-7; discussion 67-9. doi: 10.1227/01.NEU.0000335071.37943.40.</citation>
    <PMID>18728569</PMID>
  </reference>
  <reference>
    <citation>Pujari S, Kharkar S, Metellus P, Shuck J, Williams MA, Rigamonti D. Normal pressure hydrocephalus: long-term outcome after shunt surgery. J Neurol Neurosurg Psychiatry. 2008 Nov;79(11):1282-6. doi: 10.1136/jnnp.2007.123620. Epub 2008 Mar 20.</citation>
    <PMID>18356257</PMID>
  </reference>
  <reference>
    <citation>Dusick JR, McArthur DL, Bergsneider M. Success and complication rates of endoscopic third ventriculostomy for adult hydrocephalus: a series of 108 patients. Surg Neurol. 2008 Jan;69(1):5-15.</citation>
    <PMID>18054606</PMID>
  </reference>
  <reference>
    <citation>Longatti PL, Fiorindi A, Martinuzzi A. Failure of endoscopic third ventriculostomy in the treatment of idiopathic normal pressure hydrocephalus. Minim Invasive Neurosurg. 2004 Dec;47(6):342-5.</citation>
    <PMID>15674750</PMID>
  </reference>
  <reference>
    <citation>McGirt MJ, Woodworth G, Coon AL, Thomas G, Williams MA, Rigamonti D. Diagnosis, treatment, and analysis of long-term outcomes in idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005 Oct;57(4):699-705; discussion 699-705.</citation>
    <PMID>16239882</PMID>
  </reference>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2009</study_first_submitted>
  <study_first_submitted_qc>July 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2009</study_first_posted>
  <last_update_submitted>October 1, 2012</last_update_submitted>
  <last_update_submitted_qc>October 1, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 3, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>Daniele Rigamonti</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Normal Pressure Hydrocephalus</keyword>
  <keyword>Communicating Hydrocephalus</keyword>
  <keyword>Gait disorder</keyword>
  <keyword>Cognition</keyword>
  <keyword>Shunt</keyword>
  <keyword>Endoscopic Third Ventriculostomy.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hydrocephalus</mesh_term>
    <mesh_term>Hydrocephalus, Normal Pressure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

